vimarsana.com

Page 31 - மனிதன் சேவைகள் செயலாளர் குறி காலி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

California to Reserve 40% of Vaccine Doses for Low-Income Areas

Ken Towns receives a first dose of Pfizer-BioNTech COVID-19 vaccine from UC Davis Health on Jan. 12, 2021, in Sacramento, Calif. (AP Photo/Noah Berger, Pool) (CN) California will begin reserving 40% of available Covid-19 vaccines for those living in the state’s low-income communities and ease restrictions for businesses to reopen, state officials announced Wednesday evening. The new distribution plan will reach about 8 million eligible people across 400 ZIP codes, many of which are located in the Central Valley and Los Angeles County. Officials based the decision on those deemed most vulnerable, determined by income, housing status and education. State Health and Human Services Secretary Mark Ghaly announced the plan along with easing of criteria to reopen non-essential businesses.

BECERRA hits primetime — NEWSOM, DEMOCRATS feud on SCHOOLS — GOOGLE lifting ad ban — ESHOO, MCNERNEY blast FOX, NEWSMAX, OANN

POLITICO Get the California Playbook Newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by CVS Health Xavier Becerra will join the Biden administration or remain California’s attorney general. Senate confirmation hearings for Becerra’s Health and Human Services secretary nomination will launch today, with the Senate HELP Committee kicking things off. The slow-burn process has left legions of Californian politicians hoping to succeed Becerra as AG in a holding pattern, with Gov. Gavin Newsom stating recently that he will not name a replacement until and unless Becerra makes it through the confirmation process. Sen.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.